Moreover, ORAI3 enrichment sustains cancer stem cell traits and platinum resistance in NSCLC, whereas its pharmacological or genetic silencing restores chemosensitivity and reduces stemness markers [43]. This evidence concerns the gene ORAI3 and non-small cell lung carcinoma.